D J Sheridan. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » Adrenergic alpha-Antagonists/therapeutic useAnimalsArrhythmias, Cardiac/drug therapyArrhythmias, Cardiac/physiopathologyCatecholamines/metabolismCatecholamines/physiologyCoronary Disease/drug therapyCoronary Disease/physiopathologyGuinea PigsHumansIndoramin/pharmacologyMethoxamine/pharmacologyMyocardial Contraction/drug effectsPhentolamine/pharmacologyPrazosin/pharmacologyReceptors, Adrenergic, alpha/drug effectsReceptors, Adrenergic, alpha/physiologyStimulation, ChemicalSwine
Substances： See more » Adrenergic alpha-AntagonistsCatecholaminesReceptors, Adrenergic, alphaIndoraminMethoxaminePrazosinPhentolamine
Year: 1986 PMID： 2879939 DOI： 10.1016/s0022-2828(86)80461-8
Source DB: PubMed Journal: J Mol Cell Cardiol ISSN： 0022-2828 Impact factor: 5.000